FAMILIAL FACTORS ASSOCIATED WITH MALIGNANT GLIOMAS

被引:20
|
作者
WRENSCH, MR [1 ]
BARGER, GR [1 ]
机构
[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT NEUROL SURG,BRAIN TUMOR RES CTR,SAN FRANCISCO,CA 94143
关键词
astrocytoma; breast neoplasms; epidemiology; family characteristics; glioblastoma multiforme; glioma; lung neoplasms;
D O I
10.1002/gepi.1370070407
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Family histories of male patients with histologically confirmed malignant gliomas were compared to family histories of controls (wives). Included were 77 case families with 892 relatives and 77 control families with 719 relatives. Cases had significantly more siblings than controls (P = 0.02), although cases were not preferentially the oldest or the youngest sibs. Odds ratios of two or more were found for mental retardation, Parkinson's disease, and meningitis for the relatives of cases versus controls, but none were statistically significant. The excesses of Parkinson's disease and meningitis were explained by the family of one particularly interesting case containing three relatives with meningitis and two relatives with Parkinson's disease. Noteworthy age‐adjusted odds ratios for cancer among relatives of cases compared to relatives of controls were 1.6 (95% confidence interval (CI) = 1.0–2.3) for cancer of any site, 2.4 (95% CI = 0.8–6.1) for breast cancer, and 4.0 (95% CI = 0.6–10.7) for lung cancer. Only the odds ratio for cancer of any site was statistically significant. Overall, 6 of 77 (8%) of cases came from families that included two or more relatives with breast or lung cancer in addition to the proband with malignant glioma. These three cancer sites may form familial clusters worthy of further evaluation in future studies by pedigree and genetic linkage analyses. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:291 / 301
页数:11
相关论文
共 50 条
  • [41] Malignant gliomas - radiotherapy
    Schratter-Sehn, Annemarie
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2006, 156 (11-12) : 342 - 345
  • [42] Immunobiology of malignant gliomas
    Tada, M
    deTribolet, N
    JOURNAL OF CLINICAL NEUROSCIENCE, 1996, 3 (02) : 102 - 113
  • [43] Immunostimulants for Malignant Gliomas
    Butowski, Nicholas
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (01) : 53 - +
  • [44] IMMUNOTHERAPY OF MALIGNANT GLIOMAS
    JAECKLE, KA
    SEMINARS IN ONCOLOGY, 1994, 21 (02) : 249 - 259
  • [45] Recurrent Malignant Gliomas
    Kirkpatrick, John P.
    Sampson, John H.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (04) : 289 - 298
  • [46] Malignant gliomas in children
    Johnson, JH
    Phillips, PC
    CANCER INVESTIGATION, 1996, 14 (06) : 609 - 621
  • [47] CHEMOTHERAPY FOR MALIGNANT GLIOMAS
    KORNBLITH, PL
    WALKER, M
    JOURNAL OF NEUROSURGERY, 1988, 68 (01) : 1 - 17
  • [48] Microsurgery for malignant gliomas
    Yasargil, MG
    Kadri, PAS
    Yasargil, DCH
    JOURNAL OF NEURO-ONCOLOGY, 2004, 69 (1-3) : 67 - 81
  • [49] Bevacizumab for Malignant Gliomas
    Iwamoto, Fabio M.
    Fine, Howard A.
    ARCHIVES OF NEUROLOGY, 2010, 67 (03) : 285 - 288
  • [50] Malignant gliomas.
    Burton E.C.
    Prados M.D.
    Current Treatment Options in Oncology, 2000, 1 (5) : 459 - 468